Quantifying the Value of Proactive vs. Reactive Patient Input in the Drug Development Lifecycle
Time: 10:00 am
day: Day One
Details:
- Identifying critical times in drug development life cycle where advocacy and patient engagement provide valuable insights
- Determining the optimal timing to ask proactive questions to maximize engagement effectiveness
- Navigating organizational structures to advocate for proactive patient engagement and making a compelling case to teams focused on other metrics
